JP2017511368A5 - - Google Patents

Download PDF

Info

Publication number
JP2017511368A5
JP2017511368A5 JP2016562898A JP2016562898A JP2017511368A5 JP 2017511368 A5 JP2017511368 A5 JP 2017511368A5 JP 2016562898 A JP2016562898 A JP 2016562898A JP 2016562898 A JP2016562898 A JP 2016562898A JP 2017511368 A5 JP2017511368 A5 JP 2017511368A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
grams
stereoisomer
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016562898A
Other languages
English (en)
Japanese (ja)
Other versions
JP6678116B2 (ja
JP2017511368A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2015/052814 external-priority patent/WO2015159265A1/en
Publication of JP2017511368A publication Critical patent/JP2017511368A/ja
Publication of JP2017511368A5 publication Critical patent/JP2017511368A5/ja
Application granted granted Critical
Publication of JP6678116B2 publication Critical patent/JP6678116B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016562898A 2014-04-18 2015-04-17 抗菌剤を含む医薬組成物 Expired - Fee Related JP6678116B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1407/MUM/2014 2014-04-18
IN1407MU2014 2014-04-18
PCT/IB2015/052814 WO2015159265A1 (en) 2014-04-18 2015-04-17 Pharmaceutical compositions comprising antibacterial agents

Publications (3)

Publication Number Publication Date
JP2017511368A JP2017511368A (ja) 2017-04-20
JP2017511368A5 true JP2017511368A5 (https=) 2018-06-07
JP6678116B2 JP6678116B2 (ja) 2020-04-08

Family

ID=53276202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016562898A Expired - Fee Related JP6678116B2 (ja) 2014-04-18 2015-04-17 抗菌剤を含む医薬組成物

Country Status (8)

Country Link
US (1) US10857138B2 (https=)
EP (1) EP3131583A1 (https=)
JP (1) JP6678116B2 (https=)
KR (1) KR102173632B1 (https=)
CN (1) CN107980000A (https=)
BR (1) BR112016024235A2 (https=)
MX (1) MX2016013431A (https=)
WO (1) WO2015159265A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10417727B2 (en) * 2016-09-26 2019-09-17 Uber Technologies, Inc. Network system to determine accelerators for selection of a service
EP3301094A1 (en) * 2016-09-30 2018-04-04 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
KR102354697B1 (ko) * 2017-03-02 2022-01-21 욱크하르트 리미티드 항박테리아 화합물로서의 헤테로고리 유도체
US10085999B1 (en) * 2017-05-10 2018-10-02 Arixa Pharmaceuticals, Inc. Beta-lactamase inhibitors and uses thereof
WO2019093450A1 (ja) * 2017-11-10 2019-05-16 塩野義製薬株式会社 ジアザビシクロオクタン誘導体
EP3744722A4 (en) 2018-01-25 2021-11-03 Suzhou Sinovent Pharmaceuticals Co., Ltd. Ss-LACTAMASE INHIBITOR AND ITS USE
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
EP3833665B1 (en) 2018-08-09 2023-07-19 Antabio SAS Diazabicyclooctanones as inhibitors of serine beta-lactamases
CA3238268A1 (en) 2021-11-17 2023-05-25 Xufan WANG ?-lactamase inhibitor intermediate and preparation method therefor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US342553A (en) * 1886-05-25 Induction-coil
US2874279A (en) 1952-08-06 1959-02-17 Itt Pulse selector circuit
MX348974B (es) * 2011-08-27 2017-07-04 Wockhardt Ltd Derivados 1,6 - diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
CA2845108C (en) * 2011-08-30 2015-06-16 Wockhardt Limited 1,6-diazabicyclo[3,2,1]octan-7-one derivatives and their use in the treatment of bacterial infections
CA2846107C (en) * 2011-09-13 2016-06-21 Wockhardt Limited Nitrogen containing compounds and their use
US8796257B2 (en) * 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
US8940897B2 (en) * 2012-03-30 2015-01-27 Cubist Pharmaceuticals, Inc. 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
US8916709B2 (en) * 2012-03-30 2014-12-23 Cubist Pharmaceuticals, Inc. 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors
HUE046893T2 (hu) 2012-05-30 2020-04-28 Meiji Seika Pharma Co Ltd Új ß-laktamáz inhibitor és eljárás elõállítására
KR20150089086A (ko) 2013-01-14 2015-08-04 욱크하르트 리미티드 박테리아 감염을 치료하기 위한 조성물 및 방법

Similar Documents

Publication Publication Date Title
JP2017511368A5 (https=)
JP2009534386A5 (https=)
JP2012533546A5 (https=)
RU2015101102A (ru) Гетероароматическое метильное производное циклического амина
CN105919998B (zh) 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂
JP2012513416A5 (https=)
JP2019526596A5 (https=)
SI3018132T1 (en) Condensed imidazole derivatives useful as IDO inhibitors
JP2010524932A5 (https=)
JP2017505293A5 (https=)
JP2012532136A5 (https=)
JP2015501833A5 (https=)
JP2015500843A5 (https=)
JP2012525431A5 (https=)
JP2016540742A5 (https=)
JP2018502906A5 (https=)
JP2014534981A5 (https=)
JP2011509301A5 (https=)
JP2013542267A5 (https=)
JP2010132677A5 (https=)
JP2016540811A5 (https=)
JP2013537240A5 (https=)
JP2014532754A5 (https=)
JP2019513745A5 (https=)
JP2014530852A5 (https=)